Chyau, C.-C.; Wang, H.-F.; Zhang, W.-J.; Chen, C.-C.; Huang, S.-H.; Chang, C.-C.; Peng, R.Y.
Antrodan Alleviates High-Fat and High-Fructose Diet-Induced Fatty Liver Disease in C57BL/6 Mice Model via AMPK/Sirt1/SREBP-1c/PPARγ Pathway. Int. J. Mol. Sci. 2020, 21, 360.
https://doi.org/10.3390/ijms21010360
AMA Style
Chyau C-C, Wang H-F, Zhang W-J, Chen C-C, Huang S-H, Chang C-C, Peng RY.
Antrodan Alleviates High-Fat and High-Fructose Diet-Induced Fatty Liver Disease in C57BL/6 Mice Model via AMPK/Sirt1/SREBP-1c/PPARγ Pathway. International Journal of Molecular Sciences. 2020; 21(1):360.
https://doi.org/10.3390/ijms21010360
Chicago/Turabian Style
Chyau, Charng-Cherng, Hsueh-Fang Wang, Wen-Juan Zhang, Chin-Chu Chen, Shiau-Huei Huang, Chun-Chao Chang, and Robert Y. Peng.
2020. "Antrodan Alleviates High-Fat and High-Fructose Diet-Induced Fatty Liver Disease in C57BL/6 Mice Model via AMPK/Sirt1/SREBP-1c/PPARγ Pathway" International Journal of Molecular Sciences 21, no. 1: 360.
https://doi.org/10.3390/ijms21010360
APA Style
Chyau, C.-C., Wang, H.-F., Zhang, W.-J., Chen, C.-C., Huang, S.-H., Chang, C.-C., & Peng, R. Y.
(2020). Antrodan Alleviates High-Fat and High-Fructose Diet-Induced Fatty Liver Disease in C57BL/6 Mice Model via AMPK/Sirt1/SREBP-1c/PPARγ Pathway. International Journal of Molecular Sciences, 21(1), 360.
https://doi.org/10.3390/ijms21010360